Milena Fava

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

A. Levis, D. Cilloni, F. Messa, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Significant C orrelation B etween t he D egree o f WT1 Expression and t he I nternational P rognostic S coring S ystem S core i n Patients W ith M yelodysplastic S yndromes

A. Levis, D. Cilloni, F. Messa, 2003 .

Molecular monitoring in patients with chronic myelogenous leukemia

D. Cilloni, G. Saglio, E. Gottardi, 2008, Current hematologic malignancy reports.

Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation

M. Baccarani, D. Cilloni, F. Messa, 2004, Cancer.

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

V. V. D. van der Velden, R. Hills, S. Schnittger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

F. Lo‐Coco, G. Martinelli, M. Sanz, 2008, Haematologica.

Real-time quantitative PCR (RQ-PCR) detection of minimal residual disease (MRD) by optimized WT1 assay to enhance risk stratification in acute myeloid leukemia (AML): A European leukemia net study [Abstract]

R. Hills, S. Schnittger, C. Preudhomme, 2007 .

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.

D. Cilloni, F. Messa, G. Saglio, 2003, Blood.

Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.

F. Lo‐Coco, D. Cilloni, F. Messa, 2003, Blood.

WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia

M. Baccarani, M. Rondoni, G. Martinelli, 2007, Leukemia.